IP Library Granted Patent US 7,226,902
Granted Patent B2
US 7,226,902 · App. 10/799,162 · Granted Jun 5, 2007

Ligands for TGF-beta binding proteins and uses thereof

Assignee: Celltech R&D, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,226,902
App. No.
10/799,162
Granted
Jun 5, 2007
Kind
B2
Abstract

Compositions and methods are provided that relate to the unexpected specific association of (i) the TGF-beta binding protein sclerostin with the BMP antagonist protein chordin to form a complex, and of (ii) the TGF-beta binding protein sclerostin with the BMP antagonist protein noggin to form a complex, either of which complex is incapable of binding to a TGF-beta superfamily member such as a BMP. The invention provides isolated complexes for use in screening assays to identify agents that modulate bone mineralization, and offers other related advantages.

Claims (3)

1. An isolated complex comprising a TGF-beta binding protein and a BMP antagonist protein in specific association, wherein: (i) the TGF-beta binding protein comprises a sclerostin polypeptide that is capable of specifically binding a first TGF-beta superfamily member polypeptide that is selected from the group consisting of a BMP-5 polypeptide and a BMP-6 polypeptide, and (ii) the BMP antagonist protein is selected from the group consisting of a Chordin polypeptide and a Noggin polypeptide, said BMP antagonist protein being capable of specifically binding at least one second TGF-beta superfamily member polypeptide that is selected from the group consisting of a BMP-2 polypeptide, a BMP-4 polypeptide and a BMP-7 polypeptide, and wherein the complex is incapable of binding to the first TGF-beta superfamily member polypeptide.

2. An isolated complex comprising a first and a second TGF-beta binding protein in specific association, wherein; (a) the first TGF-beta binding protein is capable of binding a first TGF-beta superfamily member that is a first cognate ligand; and (b) the second TGF-beta binding protein is capable of binding a second TGF-beta superfamily member that is a second cognate ligand; wherein the complex is incapable of binding to either of the first and second cognate ligands, and wherein the first TGF-beta binding protein comprises a sclerostin polypeptide and the first cognate ligand is at least one polypeptide selected from the group consisting of BMP-2, BMP-4, BMP-5, BMP-6 and BMP-7, and wherein the second TGF-beta binding protein comprises a chordin polypeptide and the second cognate ligand is a polypeptide selected from the group consisting of BMP 2, BMP-4 and BMP-7.

3. An isolated complex comprising a first and a second TGF-beta binding protein in specific association, wherein; (a) the first TGF-beta binding protein is capable of binding a first TGF-beta superfamily member that is a first cognate ligand; and (b) the second TGF-beta binding protein is capable of binding a second TGF-beta superfamily member that is a second cognate ligand; wherein the complex is incapable of binding to either of the first and second cognate ligands, and wherein the first TGF-beta binding protein comprises a sclerostin polypeptide and the first cognate ligand is a polypeptide selected from the group consisting of BMP-5 and BMP-6, and wherein the second TGF-beta binding protein comprises a noggin polypeptide and the second cognate ligand is a polypeptide selected from the group consisting of BMP-2, BMP-4, BMP-7, and GDF-5.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2014
From: UCB MANUFACTURING, INC.
To: UCB PHARMA S.A.
Reel/Frame 033516/0394 →
MERGER Recorded Jul 15, 2014
From: DARWIN MOLECULAR CORPORATION
To: UCB MANUFACTURING, INC.
Reel/Frame 033316/0910 →
DISSOLUTION OF CELLTECH R&D, INC. AND SUBSEQUENT DISTRIBUTION OF ASSETS INTO DARWIN MOLECULAR CORPORATION Recorded Jul 15, 2014
From: CELLTECH R&D, INC.
To: DARWIN MOLECULAR CORPORATION
Reel/Frame 033330/0074 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2005
From: WINKLER, DAVID G.; LATHAM, JOHN; SKONIER, JOHN; SHPEKTOR, DIANA; HAYES, TRENTON; GEOGHEGAN, JAMES
To: CELLTECH R&D, INC.
Reel/Frame 016728/0298 →
Continuity (2)
Provisional Application 6045525300 · Mar 14, 2003
Related Publication 20050085418A1 · Apr 21, 2005